Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ouabain is not detectable in human plasma

L K Lewis1, T G Yandle, J G Lewis

  • 1Department of Medicine, Christchurch Hospital, New Zealand.

Hypertension (Dallas, Tex. : 1979)
|November 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Global Trends and Forecast of Cardiovascular Diseases, Cancer, and Shared Risk Factors: Insights From the GBD 2021.

Journal of the American Heart Association·2025
Same author

Crosstalk analysis in quantum networks: detection and localization insights with photon counting OTDR.

Optics express·2025
Same author

VEGF-A cis-located SNPs on human chromosome 6 associated with VEGF-A plasma levels and survival in a coronary disease cohort.

BMC cardiovascular disorders·2025
Same author

Physiotherapy for people with dementia: a Call to Action for the development of clinical guidelines.

Physiotherapy·2024
Same author

Short communication: Manipulation of neonatal leptin profile via exogenous glucocorticoids in beef calves.

Animal : an international journal of animal bioscience·2019
Same author

Relationships between older adults' use of time and cardio-respiratory fitness, obesity and cardio-metabolic risk: A compositional isotemporal substitution analysis.

Maturitas·2018
Same journal

Brain Iron in Nucleus Accumbens and Cognitive Function in Preeclampsia.

Hypertension (Dallas, Tex. : 1979)·2026
Same journal

Hypertension Treatment Intentions: A Health Belief Model Analysis.

Hypertension (Dallas, Tex. : 1979)·2026
Same journal

Changes in Retinal Microvasculature During Healthy Pregnancy Measured by AO.

Hypertension (Dallas, Tex. : 1979)·2026
Same journal

Longitudinal Maternal IgG and IgA Glycosylation Profiles in Pregnancy Reveal Early Immune Alterations in Placenta-Related Complications: The Rotterdam Periconception Cohort.

Hypertension (Dallas, Tex. : 1979)·2026
Same journal

Blood Pressure Variability and Outcomes Across Antihypertensive Regimens.

Hypertension (Dallas, Tex. : 1979)·2026
Same journal

Rural Health and Health Disparities in Hypertension Management: A Scientific Statement From the American Heart Association.

Hypertension (Dallas, Tex. : 1979)·2026
See all related articles

This study developed a specific enzyme-linked immunosorbent assay for measuring ouabain in human plasma. The assay suggests that if ouabain is present in circulation, its concentration is extremely low, below 0.005 nmol/L.

Area of Science:

  • Biochemistry
  • Analytical Chemistry
  • Pharmacology

Background:

  • Ouabain, a cardiac glycoside, plays a role in cardiovascular regulation.
  • Accurate measurement of endogenous ouabain in human plasma is crucial for understanding its physiological and pathological roles.
  • Existing assays may lack the specificity and sensitivity required for detecting low circulating levels.

Purpose of the Study:

  • To develop and validate a highly specific enzyme-linked immunosorbent assay (ELISA) for quantifying ouabain in human plasma.
  • To determine the physiological concentration of ouabain in the human circulation.
  • To assess the reliability and specificity of the developed immunoassay.

Main Methods:

  • Development of a specific enzyme-linked immunosorbent assay (ELISA) for ouabain.

Related Experiment Videos

  • Extraction of plasma samples and subsequent immunoassay.
  • High-performance liquid chromatography (HPLC) coupled with immunoassay for enhanced specificity.
  • Analysis of plasma samples from healthy volunteers.

    • Main Results:

    • The developed ELISA demonstrated specificity for ouabain, strophanthidin, and ouabagenin, with minimal cross-reactivity to other steroids and hormones.
    • Assay sensitivity reached <0.005 nmol/L with a 20 mL plasma extraction volume.
    • HPLC analysis indicated that the immunoreactive material in human plasma was not authentic ouabain, suggesting its concentration is below the assay's limit of detection.

    Conclusions:

    • The developed immunoassay is specific for ouabain and its related compounds.
    • Evidence suggests that endogenous ouabain concentrations in human circulation are below 0.005 nmol/L.
    • Further validation using HPLC is recommended to confirm the identity of circulating ouabain-like substances.